|2.||Severe Acute Respiratory Syndrome
|1.||Bergmann, Cornelia C: 5 articles (03/2010 - 04/2005)|
|2.||Stohlman, Stephen A: 5 articles (03/2010 - 04/2005)|
|3.||Baric, Ralph S: 3 articles (01/2015 - 05/2014)|
|4.||Rottier, Peter J M: 3 articles (01/2011 - 01/2009)|
|5.||de Haan, Cornelis A M: 3 articles (01/2011 - 01/2009)|
|6.||Hinton, David R: 3 articles (03/2010 - 04/2005)|
|7.||Atkinson, Roscoe: 3 articles (03/2010 - 01/2008)|
|8.||Perlman, Stanley: 3 articles (01/2010 - 09/2005)|
|9.||Makino, Shinji: 3 articles (06/2009 - 02/2007)|
|10.||Huang, Cheng: 3 articles (06/2009 - 02/2007)|
|1.||Antiviral Agents (Antivirals)IBA
05/01/2015 - "However, no studies have previously reported a structural platform for the design of antiviral drugs with activities against these viruses or on the efficacy of 3CLpro inhibitors against coronavirus infection in experimental animals. "
11/01/2014 - "New viral respiratory tract infections with epidemic potential, such as severe acute respiratory syndrome, swine-origin influenza A H1N1, and Middle East respiratory syndrome coronavirus infection, require development of new antiviral agents. "
01/01/1998 - "Protection against coronavirus infections can be provided by the oral administration of virus neutralizing antibodies. "
12/01/2014 - "Broadly neutralizing antibodies (nAbs) that prevent infection of related viruses represent an important immunostrategy for combating coronavirus infections; however, for this strategy to succeed, it is essential to uncover nAb-mediated escape pathways and to pioneer strategies that prevent escape. "
01/01/2009 - "Serology results, from a neutralizing antibody assay, were considered positive if the sera inhibited the development of a severe acute respiratory syndrome-associated coronavirus-specific cytopathic effect at a dilution of > or =1:8. Neutralizing antibody to severe acute respiratory syndrome-associated coronavirus was demonstrated in 8 of 25 children admitted with suspect severe acute respiratory syndrome-associated coronavirus infection. "
01/01/2007 - "Inhibition of severe acute respiratory syndrome-associated coronavirus infection by equine neutralizing antibody in golden Syrian hamsters."
01/01/2005 - "Protection of mammalian cells from severe acute respiratory syndrome coronavirus infection by equine neutralizing antibody."
11/01/1983 - "Intranasal interferon as protection against experimental respiratory coronavirus infection in volunteers."
01/01/2010 - "Autocrine interferon priming in macrophages but not dendritic cells results in enhanced cytokine and chemokine production after coronavirus infection."
01/01/1983 - "Interferon induction in rotavirus and coronavirus infections: a review of recent results."
|4.||Proteasome Endopeptidase Complex (Proteasome)IBA
|5.||FOY 305 (camostat)IBA
|6.||Proteins (Proteins, Gene)IBA
10/01/1995 - "The aim of this study was to evaluate the use of recombinant, bacterial expressed proteins in the serodiagnosis of coronavirus infections. "
01/01/2015 - "Investigation of the functional roles of host cell proteins involved in coronavirus infection using highly specific and scalable RNA interference (RNAi) approach."
09/01/2014 - "In contrast, the role of IFITM proteins in coronavirus infection is less well defined. "
01/01/2011 - "Indeed, depletion of a small subset of the affected proteins by using small interfering RNAs identified several host factors involved in coronavirus infection. "
04/01/2008 - "The emergence of the severe acute respiratory syndrome coronavirus (SARS-CoV) has led to a renewed interest in studying the role of accessory proteins in regulating coronavirus infections in the natural host. "
02/01/2013 - "Previous studies have reported that a prokaryotic-expressed recombinant nucleocapsid protein (NP) is a suitable reagent for the epidemiological screening of coronavirus infection. "
11/01/2015 - "Antibody against nucleocapsid protein predicts susceptibility to human coronavirus infection."
02/01/2014 - "Use of recombinant nucleocapsid proteins for serological diagnosis offeline coronavirus infection by three immunochromatographic tests."
02/01/2013 - "Immunoreactivity characterisation of the three structural regions of the human coronavirus OC43 nucleocapsid protein by Western blot: implications for the diagnosis of coronavirus infection."
07/01/2005 - "Evaluation of inapparent nosocomial severe acute respiratory syndrome coronavirus infection in Vietnam by use of highly specific recombinant truncated nucleocapsid protein-based enzyme-linked immunosorbent assay."
|8.||Interferon Type IIBA
02/01/2007 - "This study demonstrates a unique and crucial role of plasmacytoid dendritic cells (pDCs) and pDC-derived type I interferons (IFNs) in the pathogenesis of mouse coronavirus infection. "
01/01/2008 - "Type I interferons are essential in controlling neurotropic coronavirus infection irrespective of functional CD8 T cells."
02/01/2007 - "Control of coronavirus infection through plasmacytoid dendritic-cell-derived type I interferon."
05/01/2012 - "Protective role of Toll-like Receptor 3-induced type I interferon in murine coronavirus infection of macrophages."
|9.||Staphylococcal Protein A (A, Protein)IBA
04/01/2012 - "This study reveals that pRb and its interaction with Nsp15 can affect coronavirus infection and adds coronaviruses to a small but growing family of RNA viruses that encode a protein to interact with pRb."
10/14/2014 - "The MERS-CoV spike (S) protein, a characteristic structural component of the viral envelope, is considered as a key target of vaccines against coronavirus infection. "
08/01/2014 - "Registered therapeutics for the treatment of coronavirus infections are not available. "
01/01/2013 - "As a definitive treatment regimen has never been thoroughly evaluated for coronavirus infections, there is an urgent need to rapidly identify potential therapeutics to address future cases of nCoV. "
|5.||Transplantation (Transplant Recipients)